A Toscafund‑led consortium has agreed to take Spire Healthcare private for £1.03bn, ending a decade of public trading for the UK’s largest independent integrated healthcare network. The cash offer of 250p per share values Spire’s equity at roughly £1,026.5m, a 66.2% premium over its last closing price. Spire’s chair‑designate, Debbie White, said the deal provides certain cash value to shareholders and will improve access to capital for growth and acquisitions.

Toscafund, already a major shareholder, teamed with Three Hills, Ares, and Song Capital, which supplies about £500m of debt financing. The transaction follows a strategic review that began in September 2025 and the departure of earlier suitors such as Bridgepoint and Triton. Recent activity includes the sale of 12 acute‑care hospitals to Blue Owl Capital for £1.3bn.

Leadership changes are underway: CEO Justin Ash will retire, Sir David Sloman will become interim CEO, and Debbie White will serve as interim chair. Spire operates 38 private hospitals and over 55 clinics across England, Wales, and Scotland, treating about 1.36m patients in 2025.